My Account Contact Us
Background

Content Library

Filter
Type
Topic
Product
A4B7_Hero Case Study
  • May 16, 2023
Morphic Therapeutic leverages digital chemistry strategy to design a novel small molecule inhibitor of α4β7 integrin

Learn More
Design of a novel potent CDC7 inhibitor development candidate with high ligand efficiency and optimized properties Case Study
  • Aug 4, 2023
Design of a novel, potent CDC7 inhibitor development candidate with high ligand efficiency and optimized properties

Learn More
Case-study_MALT1-inhibitor Case Study
  • Jul 11, 2023
Hit to development candidate in 10 months: Rapid discovery of a novel, potent MALT1 inhibitor

Learn More
Wee1 Case Study
  • Jul 19, 2023
High precision, computationally-guided discovery of highly selective Wee1 inhibitors for the treatment of solid tumors

Learn More
Case-study_Nimbus-ACC Case Study
  • Jul 13, 2023
Discovery of a novel, potent ACC inhibitor driven by computationally-guided design and assessment of water energetics in the binding site

Learn More
Driving-innovation-in-polymer-r&d-with-molecular-simulation-&-machine-learning_hero Case Study
  • May 17, 2023
Schrödinger solutions for small molecule protonation state enumeration and pKa prediction

Learn More
Indiana Biosciences Research Institute enables drug discovery using CDD Vault and Schrödinger LiveDesign Case Study
  • Jun 14, 2023
Indiana Biosciences Research Institute enables drug discovery using CDD Vault and Schrödinger LiveDesign

Learn More
Hit to lead design of novel d-amino-acid oxidase inhibitors using a comprehensive digital chemistry strategy Case Study
  • Feb 11, 2022
Hit to lead design of novel d-amino-acid oxidase inhibitors using a comprehensive digital chemistry strategy

Learn More
Stories from drug discovery: Dialing out off-target liabilities with protein residue mutation FEP+ in an active drug discovery project Case Study
  • Sep 7, 2021
Stories from drug discovery: Dialing out off-target liabilities with protein residue mutation FEP+ in an active drug discovery project

Learn More
Stories from drug discovery: Modeling strategies in the pursuit of development candidate in oncology program 1 Case Study
  • Sep 4, 2021
Stories from drug discovery: Modeling strategies in the pursuit of development candidate in oncology program 1

Learn More
An expedited gene-to-drug approach using thermo scientific cryo-em and the Schrödinger platform Case Study
  • Sep 1, 2021
An expedited gene-to-drug approach using thermo scientific cryo-em and the Schrödinger platform

Learn More
dark theme background

Latest insights from Extrapolations blog

With FEP+, “The Experiment is the Limit.”
With FEP+, “The Experiment is the Limit.”

Over the past century, small molecule drugs have represented the dominant modality in drug research, enabling medical breakthroughs that have saved countless lives.

Read more
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods (FEP)
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods

The complexity and size of drug candidates has grown in recent years as scientists pursue novel targets once considered undruggable.

Read more
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In Blog
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In

We recently sat down with Edward Miller, Senior Director of Protein Structure Modeling at Schrödinger, to discuss his experience using AlphaFold models for SBDD.

Read more
View more

Training & Resources

Online certification courses

Level up your skill set with hands-on, online molecular modeling courses. These self-paced courses cover a range of scientific topics and include access to Schrödinger software and support.

Learn More

Free learning resources

Learn how to deploy the technology and best practices of Schrödinger software for your project success. Find training resources, tutorials, quick start guides, videos, and more.

Learn More
Other Resources